M&T Bank’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-99,090
| Closed | -$1.3M | – | 1623 |
|
|
2024
Q4 | $1.3M | Buy |
99,090
+13,826
| +16% | +$191K | ﹤0.01% | 813 |
|
|
2024
Q3 | $988K | Buy |
85,264
+14,247
| +20% | +$134K | ﹤0.01% | 908 |
|
|
2024
Q2 | $536K | Buy |
71,017
+7,221
| +11% | +$59.7K | ﹤0.01% | 1087 |
|
|
2024
Q1 | $639K | Buy |
63,796
+15,025
| +31% | +$140K | ﹤0.01% | 1042 |
|
|
2023
Q4 | $453K | Buy |
48,771
+3,157
| +7% | +$32.7K | ﹤0.01% | 1160 |
|
|
2023
Q3 | $579K | Sell |
45,614
-1,328
| -3% | -$18.2K | ﹤0.01% | 1026 |
|
|
2023
Q2 | $667K | Buy |
46,942
+4,707
| +11% | +$66.1K | ﹤0.01% | 1016 |
|
|
2023
Q1 | $630K | Sell |
42,235
-10,064
| -19% | -$152K | ﹤0.01% | 1032 |
|
|
2022
Q4 | $777K | Buy |
52,299
+74
| +0.1% | +$1.21K | ﹤0.01% | 945 |
|
|
2022
Q3 | $863K | Buy |
52,225
+10,627
| +26% | +$214K | ﹤0.01% | 884 |
|
|
2022
Q2 | $851K | Buy |
41,598
+23,802
| +134% | +$486K | ﹤0.01% | 828 |
|
|
2022
Q1 | $417K | Buy |
17,796
+1,227
| +7% | +$30K | ﹤0.01% | 1066 |
|
|
2021
Q4 | $451K | Buy |
16,569
+739
| +5% | +$19.8K | ﹤0.01% | 1071 |
|
|
2021
Q3 | $449K | Buy |
15,830
+60
| +0.4% | +$1.83K | ﹤0.01% | 1058 |
|
|
2021
Q2 | $475K | Buy |
15,770
+485
| +3% | +$14.3K | ﹤0.01% | 1058 |
|
|
2021
Q1 | $388K | Sell |
15,285
-5,407
| -26% | -$138K | ﹤0.01% | 1109 |
|
|
2020
Q4 | $509K | Sell |
20,692
-6,907
| -25% | -$130K | ﹤0.01% | 1044 |
|
|
2020
Q3 | $449K | Buy |
27,599
+5,609
| +26% | +$104K | ﹤0.01% | 1042 |
|
|
2020
Q2 | $375K | Sell |
21,990
-176
| -0.8% | -$2.61K | ﹤0.01% | 1082 |
|
|
2020
Q1 | $257K | Buy |
+22,166
| New | +$457K | ﹤0.01% | 1208 |
|
|
2019
Q2 | – | Sell |
-9,792
| Closed | -$266K | – | 1656 |
|
|
2019
Q1 | $266K | Buy |
9,792
+823
| +9% | +$27.6K | ﹤0.01% | 1263 |
|
|
2018
Q4 | $296K | Buy |
8,969
+2,723
| +44% | +$109K | ﹤0.01% | 1116 |
|
|
2018
Q3 | $291K | Sell |
6,246
-222
| -3% | -$10.2K | ﹤0.01% | 1244 |
|
|
2018
Q2 | $280K | Sell |
6,468
-1,623
| -20% | -$77.8K | ﹤0.01% | 1257 |
|
|
2018
Q1 | $450K | Sell |
8,091
-47
| -0.6% | -$2.58K | ﹤0.01% | 1050 |
|
|
2017
Q4 | $435K | Buy |
8,138
+1,710
| +27% | +$80.7K | ﹤0.01% | 1065 |
|
|
2017
Q3 | $277K | Sell |
6,428
-315
| -5% | -$15K | ﹤0.01% | 1265 |
|
|
2017
Q2 | $406K | Sell |
6,743
-369
| -5% | -$21.9K | ﹤0.01% | 1061 |
|
|
2017
Q1 | $494K | Sell |
7,112
-1,030
| -13% | -$71.5K | ﹤0.01% | 1001 |
|
|
2016
Q4 | $543K | Sell |
8,142
-1,067
| -12% | -$69.4K | ﹤0.01% | 1022 |
|
|
2016
Q3 | $609K | Sell |
9,209
-1,684
| -15% | -$115K | ﹤0.01% | 970 |
|
|
2016
Q2 | $790K | Sell |
10,893
-2,266
| -17% | -$156K | 0.01% | 854 |
|
|
2016
Q1 | $852K | Sell |
13,159
-1,289
| -9% | -$85.5K | 0.01% | 844 |
|
|
2015
Q4 | $1.03M | Buy |
14,448
+2,098
| +17% | +$155K | 0.01% | 774 |
|
|
2015
Q3 | $949K | Buy |
12,350
+1,576
| +15% | +$127K | 0.01% | 831 |
|
|
2015
Q2 | $798K | Sell |
10,774
-882
| -8% | -$63.5K | ﹤0.01% | 978 |
|
|
2015
Q1 | $846K | Sell |
11,656
-8,271
| -42% | -$575K | 0.01% | 942 |
|
|
2014
Q4 | $1.32M | Sell |
19,927
-3,611
| -15% | -$220K | 0.01% | 751 |
|
|
2014
Q3 | $1.29M | Buy |
+23,538
| New | +$1.34M | 0.01% | 773 |
|
Other funds holding MD
RCMNY
M&T Bank's MD Position: Q1 2025 in Review
M&T Bank sold out of Pediatrix Medical (MD) in Q1 2025, closing a stake of 99,090 shares — an estimated $1.3M sold.
M&T Bank first reported a position in MD in Q3 2014 and held it in 39 quarters. The position peaked at $1.32M in Q4 2014. 241 funds tracked by Wall St. Rank hold MD as of Q1 2025.
- M&T Bank reported no remaining Pediatrix Medical position as of Q1 2025 after selling out during the quarter.
- M&T Bank sold 99,090 Pediatrix Medical shares in Q1 2025, an estimated $1.3M.
- M&T Bank first reported a position in Pediatrix Medical in Q3 2014 and held it in 39 quarters.
- M&T Bank's Pediatrix Medical position peaked at $1.32M in Q4 2014.
- 241 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2025.
Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.